Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-2017 Volume 14 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2017 Volume 14 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway

  • Authors:
    • Lan Liu
    • Hongwei Gao
    • Hongbo Wang
    • Yuan Zhang
    • Weihua Xu
    • Sen Lin
    • Hongjuan Wang
    • Qiong Wu
    • Jianqiang Guo
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Trauma and Orthopedics, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Evidence‑Based Medicine, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
  • Pages: 3741-3747
    |
    Published online on: July 15, 2017
       https://doi.org/10.3892/ol.2017.6580
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Catalpol is an effective active ingredient that functions as a diuretic and laxative, and exhibits blood sugar‑lowering, liver protective, anti‑aging and anticancer effects. In traditional Chinese medicine, catalpol is believed to be Yin nourishing. The anticancer effect of catalpol on human HCT116 colorectal cancer cells were investigated and the mechanism of action was evaluated. Cellular viability was detected using an MTT assay. Caspase‑3 and caspase‑9 activity, cellular apoptosis and nucleic morphology were analyzed using caspase‑3 and caspase‑9 activity assay kits, flow cytometric assays and DAPI staining assay, respectively. Western blot analysis was used to measure the protein expressions of phosphatidylinositol 3‑kinase (PI3K), phosphorylated‑protein kinase B (p‑Akt) and Akt. Expression of microRNA‑200 was detected using the reverse transcription‑quantitative polymerase chain reaction. HCT116 cells were incubated with PI3K inhibitors in order to analyze the effect of catalpol on cell proliferation. Catalpol was able to inhibit HCT116 cell proliferation. Furthermore, catalpol induced apoptosis in HCT116 cells, which depended on the increased activities of caspase‑3 and ‑9. In addition, catalpol reduced the expression of PI3K, p‑Akt and Akt in HCT116 cells. However, downregulation of PI3K/Akt decreased the viability of HCT116 cells following treatment with catalpol and enhanced microRNA‑200 expression. Catalpol promoted cellular apoptosis in human HCT116 colorectal cancer cells through upregulation of microRNA‑200 expression, which depended on a downregulation of the phosphatase and tensin homolog/PI3K‑Akt signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Pandeló José D, Bartholomeeusen K, da Cunha RD, Abreu CM, Glinski J, da Costa TB, Bacchi Rabay AF, Pianowski Filho LF, Dudycz LW, Ranga U, et al: Reactivation of latent HIV-1 by new semi-synthetic ingenol esters. Virology. 462–463:328–339. 2014. View Article : Google Scholar

2 

Liu Y, Yin Z, Zhang R, Yan K, Chen L, Chen F, Huang W, Lv B, Sun C and Jiang X: MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6. Biochem Biophys Res Commun. 450:1409–1415. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 365:1687–1717. 2005. View Article : Google Scholar

4 

Tryndyak VP, Beland FA and Pogribny IP: E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer. 126:2575–2583. 2010.PubMed/NCBI

5 

Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ, et al: miR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Oncogene. 33:4077–4088. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Higgins MJ and Stearns V: Understanding resistance to tamoxifen in hormone receptor-positive breast cancer. Clin Chem. 55:1453–1455. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Jiang Y, Gong FL, Zhao GB and Li J: Chrysin suppressed inflammatory responses and the inducible nitric oxide synthase pathway after spinal cord injury in rats. Int J Mol Sci. 15:12270–12279. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Maehr T, Vecino JL, Wadsworth S, Wang T and Secombes CJ: Four CISH paralogues are present in rainbow trout Oncorhynchus mykiss: Differential expression and modulation during immune responses and development. Mol Immunol. 62:186–198. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Zhao S, Zhou L, Niu G, Li Y, Zhao D and Zeng H: Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways. FASEB J. 28:4524–4533. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Debroy A, Vogel SM, Soni D, Sundivakkam PC, Malik AB and Tiruppathi C: Cooperative signaling via transcription factors NF-κB and AP1/c-Fos mediates endothelial cell STIM1 expression and hyperpermeability in response to endotoxin. J Biol Chem. 289:24188–24201. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Yang Z, Sun D, Yan Z, Reynolds AB, Christman JW, Minshall RD, Malik AB, Zhang Y and Hu G: Differential role for p120-catenin in regulation of TLR4 signaling in macrophages. J Immunol. 193:1931–1941. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, Gladkich J, Nwaeburu CC, Mattern J, Mollenhauer M, et al: Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Oncotarget. 5:5177–5189. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Sirachainan E, Jaruhathai S, Trachu N, Panvichian R, Sirisinha T, Ativitavas T, Ratanatharathorn V, Chamnanphon M and Sukasem C: CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients. Pharmgenomics Pers Med. 5:149–153. 2012.PubMed/NCBI

14 

Cota GF, de Sousa MR, Fereguetti TO and Rabello A: Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: A systematic review with indirect comparison. PLoS Negl Trop Dis. 7:e21952013. View Article : Google Scholar : PubMed/NCBI

15 

Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002. View Article : Google Scholar : PubMed/NCBI

16 

Lyu J, Yang H, Lang J and Tan X: Tumor necrosis factor gene polymorphisms and endometriosis in Asians: A systematic review and meta-analysis. Chin Med J (Engl). 127:1761–1767. 2014.PubMed/NCBI

17 

Toyama T, Yamashita H, Sugiura H, Kondo N, Iwase H and Fujii Y: No association between CYP2D6*10 genotype and survival of node-negative Japanese breast cancer patients receiving adjuvant tamoxifen treatment. Jpn J Clin Oncol. 39:651–656. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Chamnanphon M, Pechatanan K, Sirachainan E, Trachu N, Chantratita W, Pasomsub E, Noonpakdee W, Sensorn I and Sukasem C: Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen. Pharmgenomics Pers Med. 6:37–48. 2013.PubMed/NCBI

19 

Pu Z, Yuan X, Zhang X, Chen Q and Xie H: Meta-analysis on the association between CYP2D6*10 gene polymorphism and disease free survival of breast cancer patients receiving tamoxifen treatment in Asia. Bangladesh J Pharmacol. 9:652–662. 2014. View Article : Google Scholar

20 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Lee K, Kim SJ, Kim D, Jo SH, Lee Joong S and Choi SY: Prostaglandin modulates TLR3-induced cytokine expression in human astroglioma cells. Brain Res. 1589:54–60. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Chan SM, Chadwick J, Young DL, Holmes E and Gotlib J: Intensive serial biomarker profiling for the prediction of neutropenic Fever in patients with hematologic malignancies undergoing chemotherapy: A pilot study. Hematol Rep. 6:54662014. View Article : Google Scholar : PubMed/NCBI

23 

Lee S, Pant HC and Shea TB: Divergent and convergent roles for kinases and phosphatases in neurofilament dynamics. J Cell Sci. 127:4064–4077. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Armand-Labit V and Pradines A: Circulating cell-free microRNAs as clinical cancer biomarkers. Biomol Concepts. 8:61–81. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Zheng Q, Chen C, Guan H, Kang W and Yu C: Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis. Oncotarget. Mar 29–2017.(Epub ahead of print).

26 

Tanaka S, Hosokawa M, Yonezawa T, Hayashi W, Ueda K and Iwakawa S: Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells. Biol Pharm Bull. 38:435–440. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Ning X, Shi Z, Liu X, Zhang A, Han L, Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Gao N, Tian JX, Shang YH, Zhao DY and Wu T: Catalpol suppresses proliferation and facilitates apoptosis of OVCAR-3 ovarian cancer cells through upregulating microRNA-200 and downregulating MMP-2 expression. Int J Mol Sci. 15:19394–19405. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Luo JB, Feng L, Jiang WD, Liu Y, Wu P, Jiang J, Kuang SY, Tang L, Zhang YA and Zhou XQ: The impaired intestinal mucosal immune system by valine deficiency for young grass carp (Ctenopharyngodon idella) is associated with decreasing immune status and regulating tight junction proteins transcript abundance in the intestine. Fish Shellfish Immunol. 40:197–207. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, Skaar T, Storniolo AM, Li L, Araba A, et al: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst. 97:30–39. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Sukasem C, Sirachainan E, Chamnanphon M, Pechatanan K, Sirisinha T, Ativitavas T, Panvichian R, Ratanatharathorn V, Trachu N and Chantratita W: Impact of CYP2D6 polymorphisms on tamoxifen responses of women with breast cancer: A microarray-based study in Thailand. Asian Pac J Cancer Prev. 13:4549–4553. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu L, Gao H, Wang H, Zhang Y, Xu W, Lin S, Wang H, Wu Q and Guo J: Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway. Oncol Lett 14: 3741-3747, 2017.
APA
Liu, L., Gao, H., Wang, H., Zhang, Y., Xu, W., Lin, S. ... Guo, J. (2017). Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway. Oncology Letters, 14, 3741-3747. https://doi.org/10.3892/ol.2017.6580
MLA
Liu, L., Gao, H., Wang, H., Zhang, Y., Xu, W., Lin, S., Wang, H., Wu, Q., Guo, J."Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway". Oncology Letters 14.3 (2017): 3741-3747.
Chicago
Liu, L., Gao, H., Wang, H., Zhang, Y., Xu, W., Lin, S., Wang, H., Wu, Q., Guo, J."Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway". Oncology Letters 14, no. 3 (2017): 3741-3747. https://doi.org/10.3892/ol.2017.6580
Copy and paste a formatted citation
x
Spandidos Publications style
Liu L, Gao H, Wang H, Zhang Y, Xu W, Lin S, Wang H, Wu Q and Guo J: Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway. Oncol Lett 14: 3741-3747, 2017.
APA
Liu, L., Gao, H., Wang, H., Zhang, Y., Xu, W., Lin, S. ... Guo, J. (2017). Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway. Oncology Letters, 14, 3741-3747. https://doi.org/10.3892/ol.2017.6580
MLA
Liu, L., Gao, H., Wang, H., Zhang, Y., Xu, W., Lin, S., Wang, H., Wu, Q., Guo, J."Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway". Oncology Letters 14.3 (2017): 3741-3747.
Chicago
Liu, L., Gao, H., Wang, H., Zhang, Y., Xu, W., Lin, S., Wang, H., Wu, Q., Guo, J."Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA‑200 and the downregulation of PI3K‑Akt signaling pathway". Oncology Letters 14, no. 3 (2017): 3741-3747. https://doi.org/10.3892/ol.2017.6580
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team